Mark Rutte, the head of NATO, recently shot down the idea of a separate European army. This idea has been floating around among some European leaders. They're worried about Donald Trump's dedication to Europe's safety, especially after some drama over Greenland. Rutte didn't hold back. He told supp
Mark Carney, the former Prime Minister of Canada, recently spoke at the World Economic Forum in Davos. He started by referencing a famous essay written by Vaclav Havel, a Czech playwright and former president. This essay, written in 1978, talked about how people can end up supporting bad systems, ev
Markets had a wild ride this week. It all started when the US hinted at new taxes on Europe. Suddenly, stocks, bonds, and even digital money like Bitcoin took a nosedive. This wasn't just any drop. It was a big one, and it happened everywhere at once. Traders were caught off guard. They thought the
Market calmness has taken a backseat lately. Japan's bond yields spiked after a sudden election and tax reduction plans shook investor confidence. This caused a massive sell-off in long-term bonds, reminiscent of the chaos following Trump's tariff announcements. Across the Pacific, Trump's renewed
Mark Ruffalo, a well-known actor, recently made some bold claims about President Donald Trump. He called Trump a "convicted rapist" and a "pedophile. " These statements could lead to serious legal trouble for Ruffalo. Ruffalo didn't stop there. He also made other claims while talking to the media a
Ivan Bates, Baltimore's State's Attorney, is making waves with a significant drop in crime rates. He's been in office for three years, and things are looking up. The office itself has seen a makeover, but the real change is in the way things are done. Bates has boosted the team, adding more prosecu
Ivermectin, a drug that gained fame during the pandemic, has more tricks up its sleeve. It's not just for fighting viruses anymore. Now, it's stepping into the world of skincare, offering a new way to tackle common skin issues. This cream is a powerhouse. It combines Ivermectin with two other FDA-a
Markets have been on a wild ride lately, leaving many investors confused and frustrated. With just two weeks left in the year, it's a good time to take a step back and look at the bigger picture. The S&P 500 and Nasdaq have been trading in a tight range for over two months, which is not ideal for an
Ivermectin, a drug known for fighting parasites, has been a hot topic in the fight against Covid-19. Some people believe it can lower the risk of death from the virus. Two recent studies looked at the same group of clinical trials and used similar statistical methods. Surprisingly, they came to diff
Ivermectin, a drug with a wide range of uses, is gaining attention again. It's used for treating skin conditions, parasite infections, and even shows promise in fighting cancer. However, most of the Ivermectin sold worldwide comes from Asia, with a significant portion from China. This raises concern
